A Study of ABT-414 in Subjects With Solid Tumors

Clinical trial NCT01741727 · COMPLETED

Trial details

NCT number: NCT01741727
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Tumors

Start date: 2012-10-01
Primary completion: 2015-11-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.